Benatti Luca sold QNCX
December 26, 2025 · Form 4 insider transaction
Benatti Luca sold 50,000 shares of Quince Therapeutics, Inc. at $3.47 per share, a transaction worth $173.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
50,000
Price
$3.47
Total value
$173.5K
InsiderBenatti Luca
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 26, 2025
Filing dateDecember 29, 2025
Shares owned after39,179
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The sale price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.45 to $3.56, inclusive. The reporting person undertakes to provide to Quince Therapeutics, Inc., any security holder of Quince Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.